skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I understand you are not fans of Canoe, but in the Globe & Mail Gordon Pape recently put forward a persuasive case for income investors since the unit value has been trading
between $11 and $13 for the last several years. With the current price at the low end of the range, the yield is very attractive and the monthly payment of 10 cents/unit has remained stable since 2009. Any second thoughts?
Read Answer Asked by Jean on February 06, 2019
Q: Recently n January bought 5150 shares pmif.my brokerage showed a yield of 3.5%on a monthly distribution of .0230.your site has same monthly rate and a yield of 2.7. I have just received my first Monthly payment of 118.45 on book value of 100126$ . this would be a yield of just 1.42%.can you analyze and confirm what yield I can count on?And any suggestions for any other options in fixed income to yield 3%?

Read Answer Asked by Larry on February 06, 2019
Q: Hi 5i: Am considering SCHD .. Schwab U.S. Dividend Equity ETF (symbol not in your database) for a medium to long term hold in my non-registered account. It tracks the Dow Jones U.S. Dividend 100 index. Seems to have a good track record and 5 star rating from Morningstar with a low mer of 0.07%. What is your opinion of this ETF ? Would you prefer VUN or VGG ? Any other suggestions appreciated.
Thanks as always for your great advice !
Steve
Read Answer Asked by STEVEN on February 06, 2019
Q: I am looking to add an industrial REIT (either SMU.UN, WIR.UN, or DIR.UN) to an RESP for a 5-8 year hold. Funds are not needed for another 8 years. Which of the 3 REITS listed would you recommend purchasing and why do you prefer it over the other 2?
Read Answer Asked by Linda on February 06, 2019
Q: Hello: I have been reading the last ROB and the Invest like a legend article. I find it interesting most of those interviewed mention broad index funds. You have mentioned these many times but hope you might address these funds again with a portfolio of index funds. Thank you in advance. Barbara
Read Answer Asked by Barbara on February 06, 2019
Q: Hi team,

I don't see any questions on this company Cardiol Therapeutics Inc. (CRDL) that did a recent IPO on TSX and hit a 52 week high today. It seems they are in a (speculative) cannabinoid arena with some drugs coming into phase 1 stages in 2019.
What is management history (CEO, CFO, etc.), board of directors, ...ie are they a solid team?
They had a string of announcements (LOI's, exclusive agreements, etc) in 2017 but no real follow-up news in 2018 wrt these signings.
Does their product pipeline seem promising?
How might it compare to Cannimed wrt therapeutic applications?

Is it a company to just watch for now given it's very recent IPO? So many IPO's flop in the first 6 months thus the caution.

Appreciate your insight!

Cheers,
SteveMc
Read Answer Asked by Stephen on February 06, 2019